loadpatents
Patent applications and USPTO patent grants for Calias; Pericles.The latest application filed is for "methods for treating symptomatic orthostatic hypotension".
Patent | Date |
---|---|
Methods For Treating Symptomatic Orthostatic Hypotension App 20220168301 - Calias; Pericles ;   et al. | 2022-06-02 |
Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20220133862 - Natoli; Farah ;   et al. | 2022-05-05 |
Treatment Of Sanfilippo Syndrome Type B App 20220133863 - Concino; Michael F. ;   et al. | 2022-05-05 |
Methods and compositions for CNS delivery of iduronate-2-sulfatase Grant 11,260,112 - Zhu , et al. March 1, 2 | 2022-03-01 |
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety Grant 11,065,307 - Concino , et al. July 20, 2 | 2021-07-20 |
Methods and compositions for CNS delivery of heparan n-sulfatase Grant 11,065,308 - Natoli , et al. July 20, 2 | 2021-07-20 |
Access Port System With Self-adjusting Catheter Length App 20210146108 - Calias; Pericles ;   et al. | 2021-05-20 |
Methods and Compositions for CNS Delivery of Arylsulfatase A App 20200405825 - Salamat-Miller; Nazila ;   et al. | 2020-12-31 |
Stable Formulations For Cns Delivery Of Arylsulfatase A App 20200237883 - Salamat-Miller; Nazila ;   et al. | 2020-07-30 |
Stable formulations for CNS delivery of arylsulfatase A Grant 10,660,944 - Salamat-Miller , et al. | 2020-05-26 |
Methods and compositions for CNS delivery of arylsulfatase A Grant 10,646,554 - Salamat-Miller , et al. | 2020-05-12 |
Cns Delivery Of Therapeutic Agents App 20200113981 - Calias; Pericles ;   et al. | 2020-04-16 |
Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20200046810 - Zhu; Gaozhong ;   et al. | 2020-02-13 |
CNS delivery of therapeutic agents Grant 10,456,454 - Calias , et al. Oc | 2019-10-29 |
Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20190183984 - Natoli; Farah ;   et al. | 2019-06-20 |
Stable Formulations For Cns Delivery Of Arylsulfatase A App 20190125841 - Salamat-Miller; Nazila ;   et al. | 2019-05-02 |
Treatment of Sanfilippo Syndrome Type B App 20180085438 - Concino; Michael F. ;   et al. | 2018-03-29 |
Methods And Compositions For Cns Delivery Of Arylsulfatase A App 20180071212 - Salamat-Miller; Nazila ;   et al. | 2018-03-15 |
Methods And Compositions For Intrathecally Administered Treatment Of Mucupolysaccharidosis Type Iiia App 20180036386 - HASLETT; Patrick ;   et al. | 2018-02-08 |
Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase Grant 9,814,764 - Concino , et al. November 14, 2 | 2017-11-14 |
Methods and compositions for CNS delivery of arylsulfatase A Grant 9,770,410 - Salamat-Miller , et al. September 26, 2 | 2017-09-26 |
Mrna Therapy For The Treatment Of Ocular Diseases App 20170143848 - CALIAS; Pericles ;   et al. | 2017-05-25 |
Cns Delivery Of Therapeutic Agents App 20170042978 - Calias; Pericles ;   et al. | 2017-02-16 |
Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20170042977 - Natoli; Farah ;   et al. | 2017-02-16 |
Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20160158324 - Zhu; Gaozhong ;   et al. | 2016-06-09 |
Methods and compositions for CNS delivery of heparan N-sulfatase Grant 9,320,711 - Natoli , et al. April 26, 2 | 2016-04-26 |
CNS delivery of therapeutic agents Grant 9,283,181 - Calias , et al. March 15, 2 | 2016-03-15 |
Methods Of Treating B2-bradykinin Receptor Mediated Angioedema App 20160030416 - Leach; Kevin ;   et al. | 2016-02-04 |
Methods and compositions for CNS delivery of iduronate-2-sulfatase Grant 9,220,677 - Zhu , et al. December 29, 2 | 2015-12-29 |
Methods And Compositions For Intrathecally Administered Treatment Of Mucupolysaccharidosis Type Iiia App 20150313971 - HASLETT; Patrick ;   et al. | 2015-11-05 |
Electrochemically Degradable Polymers App 20150202292 - d'Alarcao; Marc ;   et al. | 2015-07-23 |
Electrochemically Degradable Polymers App 20150175723 - Calias; Pericles ;   et al. | 2015-06-25 |
Controlled Release Microparticles App 20150037429 - Campbell; Kathleen M. ;   et al. | 2015-02-05 |
Methods for treating lysosomal acid lipase deficiency Grant 8,945,542 - Heartlein , et al. February 3, 2 | 2015-02-03 |
Stable Formulations For Cns Delivery Of Arylsulfatase A App 20140377244 - Salamat-Miller; Nazila ;   et al. | 2014-12-25 |
Controlled release microparticles Grant 8,877,229 - Campbell , et al. November 4, 2 | 2014-11-04 |
Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20140271598 - Zhu; Gaozhong ;   et al. | 2014-09-18 |
Electrochemically degradable polymers Grant 8,834,901 - d'Alarcao , et al. September 16, 2 | 2014-09-16 |
Methods For Treating Lysosomal Acid Lipase Deficiency App 20140044697 - Heartlein; Michael ;   et al. | 2014-02-13 |
Treatment Of Sanfilippo Syndrome Type B App 20130295077 - Concino; Michael F. ;   et al. | 2013-11-07 |
Methods And Compositions For Cns Delivery Of B-galactocerebrosidase App 20130295071 - Salamat-Miller; Nazila ;   et al. | 2013-11-07 |
Methods and compositions for CNS delivery of iduronate-2-sulfatase Grant 8,545,837 - Zhu , et al. October 1, 2 | 2013-10-01 |
Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20120014936 - Natoli; Farah ;   et al. | 2012-01-19 |
Methods And Compositions For Cns Delivery Of Arylsulfatase A App 20120009171 - Salamat-Miller; Nazila ;   et al. | 2012-01-12 |
Cns Delivery Of Therapeutic Agents App 20120003202 - Calias; Pericles ;   et al. | 2012-01-05 |
Methods And Compositions For Cns Delivery Of B-galactocerebrosidase App 20110318324 - Salamat-Miller; Nazila ;   et al. | 2011-12-29 |
Treatment Of Sanfilippo Syndrome Type B App 20110318327 - Concino; Michael F. ;   et al. | 2011-12-29 |
Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20110318323 - Zhu; Gaozhong ;   et al. | 2011-12-29 |
Detection of oligonucleotides by dual hybridization Grant 7,785,784 - Shima , et al. August 31, 2 | 2010-08-31 |
Electrochemically degradable polymers App 20090024074 - d'Alarcao; Marc ;   et al. | 2009-01-22 |
Immunodulatory compositions and methods of use thereof Grant 7,456,220 - Calias , et al. November 25, 2 | 2008-11-25 |
Biologically active conjugate of a biopolymer and therapeutic agent Grant 7,417,021 - Calias , et al. August 26, 2 | 2008-08-26 |
Controlled release microparticles App 20070292475 - Campbell; Kathleen M. ;   et al. | 2007-12-20 |
Detection of oligonucleotides by dual hybridization App 20070178476 - Shima; David T. ;   et al. | 2007-08-02 |
Drug delivery of proteins from polymeric blends Grant 7,189,413 - Calias , et al. March 13, 2 | 2007-03-13 |
Immunomodulatory compositions and methods of use thereof App 20060029662 - Calias; Pericles ;   et al. | 2006-02-09 |
Sequencing of modified nucleic acid molecules App 20060019298 - Shima; David T. ;   et al. | 2006-01-26 |
Enhanced biologically active conjugates App 20050260651 - Calias, Pericles ;   et al. | 2005-11-24 |
Facilitation of iontophoresis using charged moieties App 20050260153 - Calias, Pericles ;   et al. | 2005-11-24 |
Cross-linked hyaluronate compounds App 20050222081 - Gianolio, Diego A. ;   et al. | 2005-10-06 |
Drug delivery device and syringe for filling the same App 20040230183 - Breegi, Wisam ;   et al. | 2004-11-18 |
Modification of biopolymers for improved drug delivery Grant 6,749,865 - Calias , et al. June 15, 2 | 2004-06-15 |
Water insoluble derivatives of polyanionic polysaccharides Grant 6,610,669 - Calias , et al. August 26, 2 | 2003-08-26 |
Modification of biopolymers for improved drug delivery App 20030087877 - Calias, Pericles ;   et al. | 2003-05-08 |
Single phase gels for the prevention of adhesions Grant 6,521,223 - Calias , et al. February 18, 2 | 2003-02-18 |
Drug delivery of proteins from polymeric blends App 20020182254 - Calias, Pericles ;   et al. | 2002-12-05 |
SEC | 0001746282 | Calias Pericles |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.